web analytics

The 6th Leading Cause of Death by Cancer, Can Be Mitigated with Ivermectin

stock here: no wonder they attacked Ivermectin so horribly, as they want people to die from Cancer after enriching the Medical System with years of “treatment”. But make sure no one uses the safe, cheap and effective Ivermectin!!!!


Summary for Layman

This study investigates the potential of ivermectin, a drug commonly used to treat parasitic infections, as a treatment for esophageal squamous cell carcinoma (ESCC), a type of esophageal cancer prevalent in the Asia-Pacific region.

Key Findings:

  1. Ivermectin’s Effects on Cancer Cells:
    • In laboratory tests and in mice, ivermectin significantly inhibited the growth and spread of ESCC cells.
    • It reduced the ability of cancer cells to form colonies, migrate, and invade other tissues.
    • Ivermectin induced cancer cell death through mechanisms involving the mitochondria (the energy-producing parts of cells).
  2. Mechanism of Action:
    • The study found that ivermectin suppresses a protein called PAK1, which plays a crucial role in the growth and spread of ESCC cells.
    • Ivermectin promotes the degradation of PAK1 through a pathway involving the proteasome, a protein complex responsible for breaking down unwanted proteins.
  3. Combination with Chemotherapy:
    • Ivermectin enhanced the effects of traditional chemotherapy drugs like cisplatin and 5-fluorouracil, making cancer cells more susceptible to these treatments.
  4. In Vivo Results:
    • In mice models, ivermectin effectively reduced tumor growth and prevented lung metastasis (spread of cancer to the lungs).
  5. Conclusion:
    • The results suggest that ivermectin has potent anti-cancer properties against ESCC and could be a promising therapeutic candidate for patients, including those with metastasis or resistance to standard chemotherapy.

Suggested Dosing for High-Risk Humans

The study primarily used mice models and cell cultures, and it does not provide specific dosing recommendations for humans at high risk of ESCC. However, it mentions that ivermectin has been safely used in humans for over 30 years to treat parasitic infections.

Important Note:

Before considering ivermectin as a treatment for ESCC or any other type of cancer, it is crucial to consult with a healthcare professional and rely on clinical trials to determine the appropriate dosage, safety, and efficacy for cancer patients. Clinical trials would be necessary to establish the right dosing regimen and confirm its benefits and risks in humans.

Leave a Reply

Your email address will not be published. Required fields are marked *